A Prescription Drug User Fee Act target date of February 1, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) ...

Backed by founder capital and execution-focused leadership, the acquisition marks the commercial relaunch of the RxActuator Mini-Infuser ®, a validated, commercial-stage platform positioned at the ...

Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...

Questions about an infusion device have scuttled Supernus Pharmaceuticals’ attempt to win approval of a Parkinson’s disease therapy. The complete response letter marks the second time in two years ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. Unlike traditional pumps that rely on specific setups and conditions for accurate delivery, ...

GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- InVera Medical, an Irish medical technology company, has received European regulatory approval for a new minimally invasive device designed to help ...

DUBLIN--(BUSINESS WIRE)--The "Infusion Pumps and Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Infusion pumps are widely used in hospitals, ...